pyridine n-oxide has been researched along with 1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biricová, V; Hermann, P; Lázníček, M; Lázničková, A; Polášek, M | 1 |
Biricova, V; Hermann, P; Laznicek, M; Laznickova, A | 1 |
2 other study(ies) available for pyridine n-oxide and 1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane
Article | Year |
---|---|
Radiolabeling of PAMAM dendrimers conjugated to a pyridine-N-oxide DOTA analog with ¹¹¹In: Optimization of reaction conditions and biodistribution.
Topics: Animals; Dendrimers; Drug Carriers; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Isotope Labeling; Male; Pyridines; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution | 2011 |
Mono(pyridine-N-oxide) DOTA analog and its G1/G4-PAMAM dendrimer conjugates labeled with 177Lu: radiolabeling and biodistribution studies.
Topics: Animals; Chelating Agents; Dendrimers; Heterocyclic Compounds, 1-Ring; Isotope Labeling; Lutetium; Male; Pyridines; Radioisotopes; Rats; Rats, Wistar | 2014 |